Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique Type, End User and Region (North America, APAC, MEA, Europe, Latin America) - Global Forecast to 2027
[232 Pages Report] The global lateral flow assay components market is projected to reach USD 420 million by 2027 from USD 339 million in 2022, at a CAGR of 4.3% during the forecast period. The growth of the market may due to the high prevalence of infectious diseases worldwide, rapid growth in the geriatric population, the growing demand for point-of-care testing, the increased demand for lateral flow assay components due to COVID-19, and the rising use of home-based lateral flow assay devices.
On the other hand, the availability of conventional substitutes such as alternative diagnostics may restrict the growth of the lateral flow assay components market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
Impact of Covid-19 on Lateral Flow Assays Market
To assess the impact of COVID-19 and provide market forecasts, scenario-based approaches are considered.
To assess the impact of COVID-19 and provide market forecasts, scenario-based approaches are considered. The lateral flow assay components market has been positively impacted by the COVID-19 pandemic, as the need for the rapid diagnosis of the coronavirus infection has been the focus since the inception of the pandemic outbreak in December 2019. As the number of cases increased across regions, most major lateral flow assay market players invested in R&D, as well as entered into partnerships and agreements with other industry players and government agencies.
Lateral Flow Assay Components Market Dynamics:
DRIVERS: Growing demand for lateral flow assay kits due to the COVID-19 pandemic
During COVID-19, many companies launched home-based lateral flow assays for COVID-19 testing as people were afraid to get tested at diagnostic laboratories or hospitals, which supported the demand for home-based lateral flow assays. This led to the launches of several home-based assays. For example:
- The BinaxNOW COVID-19 Ag Card was launched in August 2020, and the Panbio Rapid COVID-19 test was launched in September 2020.
- Roche Diagnostics launched the SARS-CoV-2 Rapid Antigen test in September 2020.
- Other tests launched during COVID-19 include Sofia 2 Flu+ SARS Antigen FIA (Quidel Corporation), CLINITEST Rapid COVID-19 Antigen test (Danaher Corporation), and BD Veritor SARS CoV-2 Test (BD).
The pandemic also promoted cooperation between local manufacturers of lateral flow assay components and key market players to increase the supply of components to meet the increased demand for lateral flow assay kits.
Growing Usage of home-based lateral flow assay devices
Home-based lateral flow assay devices play a important role in diagnosis of cardiovascular and infectious diseases. These devices are also useful in testing pregnancy and stigmatized conditions such as HIV as they potentially empower patients to perform self-tests in their homes. Hence, the increasing incidence of these diseases and the higher adoption of lateral flow assay tests in home care settings are expected to boost the demand for lateral flow assay components in the coming years.
Growing demand for point-of-care testing
Lateral flow assay-based point-of-care (POC) tests are increasingly being adopted to replace lengthy, conventional laboratory procedures. POC diagnostic tests do not require complex infrastructures and training, owing to which the cost of these tests is lower than conventional laboratory diagnostic procedures. POC testing is anticipated to hold the greatest share in the lateral flow assays market because of its importance in combating the growing disease burden.
The rising prevalence of chronic diseases, technological advancements in diagnostic instruments, and growing patient awareness are other key factors driving the demand for lateral flow assays and lateral flow assay components. Many companies are increasingly focusing on developing innovative lateral flow assay-based POC devices for applications such as pregnancy (using hCG levels) and ovulation confirmation, infectious disease and drugs-of-abuse screening, and the measurement of protein markers in the blood. In 2019, Abbott Laboratories (US) developed its ARCHITECT STAT Troponin I Blood Test, while Siemens AG developed the CLINITEK Microalbumin 2 strips for clinical diagnostics.
The rising demand for POC testing and the increasing focus on using lateral flow assay-based POC testing devices to achieve greater portability are expected to boost the growth of the lateral flow assay components market during the forecast period.
Increasing public and private investment to develop lateral flow assayss
Medical device companies use lateral flow membranes in rapid diagnostic test kit manufacturing, enabling reproducible results due to their consistent quality and optimized properties. Rapid test kits are used for a variety of applications, including infectious disease testing (COVID-19, HIV, influenza, and malaria), as well as in women’s health, biomarker detection, drug testing, food safety, and animal health. Due to the continuously increasing demand for lateral flow membranes, public and private investors are investing in developing lateral flow assays and their components. These investments may improve the manufacturing capacity of assay components, leading to growth in the lateral flow assay components market during the forecast period. For instance:
- In December 2021, Merck invested €121 million (132.8 USD million) to construct a lateral flow membrane production facility at Sheboygan, Wisconsin, US.
- In January 2021, a UK-based diagnostics firm received an investment of USD 2.6 million from public and commercial buyers from both the US and the UK.
RESTRAINTS: Availability of alternative diagnostics technologies
Although lateral flow assay kits have many advantages like low cost, rapid detection, stability over a wide range of environmental conditions, and a very long shelf life, they are also associated with a number of disadvantages. These kits are mostly qualitative or semi-quantitative, reproducibility varies from lot to lot, they suffer from low biomolecule affinity toward analytes, the tendency of cross-reactivity, and the occasional requirement of pretreatment of samples which is time-consuming. Once a sample is applied to a strip, capillary action cannot be decreased or sped up, and the analysis time is also dependent on the nature of the sample itself, i.e., viscosity or surface tension. This limits the adoption of lateral flow assay kits to a greater extent, affecting the demand for lateral flow assay components.
OPPORTUNITY: Evolving application of lateral flow assays
The lateral flow tests are widely used for infectious disease diagnostics, the diagnosis of cardiac diseases, and veterinary applications, their use has increased in several new applications over the last few years. For instance, saliva diagnostics, behavioral health, agriculture (genetically modified organism detection and crop quality testing), biowarfare (anthrax detection), environmental testing (detection of contaminating enzymes in manufacturing plants), and food microbiology (detection of E. coli O157, Salmonella, Listeria, and other food spoilage organisms) have emerged as new application areas for lateral flow assays.
Atlas Link Technologies Co., Ltd. (China) provides the FASPIT SARS-CoV-2 Saliva Test, a saliva-based lateral flow assay kit for COVID-19. Salivary LFIAs have also penetrated the market for applications such as drugs-of-abuse testing, and several systems have been FDA-cleared for marketing; however, testing remains largely qualitative.
Due to the increasing adoption of lateral flow assays in different application areas, the demand for components will also increase.
CHALLENGES: Requirement of specialized storage and shipping facilities for membrane
Nitrocellulose membranes are biological membranes made up of nitrocellulose and have a different grade of pore size. The performance of lateral flow assay kits depends on the quality of the nitrocellulose membrane used. Nitrocellulose membranes must be stored properly to ensure maximum shelf life. These components need to be stored away from room temperature or chemical vapors, which may partially dissolve the nitrocellulose and thereby disrupt the pore structure. These are a challenges to the growth of the lateral flow assay components market in the forecast period.
Membranes segment accounted for the largest share in the lateral flow assay components market.
The lateral flow assay components market is segmented into membranes, pads, and others. In 2021, membranes accounted for the largest share of the global lateral flow assay components market. The large share of this segment can be attributed to the increasing applications of lateral flow assay kits & reagents for POC testing, and their convenience and ease of use.
The lateral flow assay membranes market is further bifurcated into nitrocellulose and other membranes. In 2021, the nitrocellulose membranes segment accounted for the largest share of the global lateral flow assay membranes market. Nitrocellulose membranes are mainly used to make lateral flow immunoassays.
The lateral flow assay pads market is further bifurcated into sample pads, conjugate pads, and absorbent pads. In 2021, the sample pads segment accounted for 56.4% of the lateral flow assay pads market.
Clinical Testing segment is expected to witness the fastest growth in the forecast period.
The lateral flow assay components market is segmented into clinical testing, veterinary diagnostics, food safety & environmental testing, and drug development & quality testing based on the application type. The clinical testing segment accounted for the largest share of the lateral flow assay components market in 2021. The large share of this segment can be attributed to the rising prevalence of chronic diseases and the increasing demand for patient-centric care.
Sandwich assays technique accounted for the largest share of lateral flow assay components market in 2021”
The lateral flow assay components market is segmented into competitive assays, sandwich assays, and multiplex detection assays. Sandwich assays dominated the lateral flow assay components market in 2021. The large share of this segment can be attributed to its better assay sensitivity and specificity as well as its extensive applications in the measurement of critical analytes
The medical device manufacturing company accounted for the largest share of lateral flow assays components market in 2021
The lateral flow assay components market is segmented into medical device manufacturing companies and medical device contract manufacturing companies. Medical device manufacturing companies accounted for the largest market share of the lateral flow assay components market in 2021. The COVID-19 pandemic has also increased the demand for point-of-care testing in professional healthcare settings, which increases the demand for lateral flow assay components among medical device manufacturing companies.
North America accounted for the largest share of the lateral flow assay components market in 2021
In 2021, North America accounted for the largest share of the lateral flow assay components market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR during the forecast period. The rapidly developing raw material industry in China and India, the growing number of local manufacturers for lateral flow assay components, increasing investments in the region by key market players, are the key factors driving market growth in the APAC.
Geographic Snapshot: Lateral Flow Assay Components Market
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players :
The prominent players in this market include Danaher Corporation (Cytiva Life Science and Pall Corporation) (US), Merck KGaA (Germany), Sartorius Stedim Biotech (Germany), Ahlstrom-Munksjö (Finland), Advanced Microdevice Pvt. Ltd. (India), Hangzhou Cobetter Filtration System Co., Ltd. (China), Axiva-Axiflow Group (India), Nupore Filtration (India), DCN Diagnostics (US), and Ballya Bio (China).
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
Request Sample Scope of the Report
Get online access to the report on the World's First Market Intelligence Cloud
- Easy to Download Historical Data & Forecast Numbers
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
|
Report Metric |
Details |
|
Market Size Available for Years |
2020–2027 |
|
Base Year Considered |
2021 |
|
Forecast Period |
2022–2026 |
|
Forecast Unit |
Value (USD Million) |
|
Segments Covered |
By type, Application type, Technique type, End User, and Region |
|
Countries Covered |
|
|
Companies Covered |
Danaher Corporation (Cytiva Life Science and Pall Corporation) (US), Merck KGaA (Germany), Sartorius Stedim Biotech (Germany), Ahlstrom-Munksjö (Finland), Advanced Microdevice Pvt. Ltd. (India), Hangzhou Cobetter Filtration System Co., Ltd. (China), Axiva-Axiflow Group (India), Nupore Filtration (India), DCN Diagnostics (US), Ballya Bio (China) among others. |
The research report lateral flow assay components market into the following segments and sub-segments:
By Type
- Membranes
- Pads
- Others
By Application
- Clinical Testing
- Veterinary Diagnostics
- Food Safety & Environmental Testing
- Drug Development & Quality Testing
By Technique
- Sandwich Assays
- Competitive Assays
- Multiplex Detection Assays
By End User
- Medical Device Manufacturing Company
- Medical Device Contract Manufacturing Company
By Country
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- Japan
- China
- India
- Australia
- Rest of APAC
- Latin America
- Middle East and Africa
Recent Developments:
- In January 2021, Merck acquired AmpTec to expand its mRNA capabilities for vaccines, treatments, and diagnostics
- In March 2020, Danaher acquired the Biopharma business of General Electric’s Life Science division known as cytiva
- In October 2019, Sartorius acquired some part of the Life Sciences business from Danaher to broaden its product portfolio
Frequently Asked Questions (FAQ):
Which are the top industry players in the lateral flow assay components market?
The prominent players in this market include Danaher Corporation (Cytiva Life Science and Pall Corporation) (US), Merck KGaA (Germany), Sartorius Stedim Biotech (Germany), Ahlstrom-Munksjö (Finland), Advanced Microdevice Pvt. Ltd. (India), Hangzhou Cobetter Filtration System Co., Ltd. (China), Axiva-Axiflow Group (India), Nupore Filtration (India), DCN Diagnostics (US), and Ballya Bio (China).
Which region is dominating in the lateral flow assay components market?
In 2021, North America accounted for the largest share of 49.4% of the lateral flow assay components market, followed by Europe, the Asia Pacific, Latin America, and the Middle East & Africa. However, the APAC region is expected to grow at the highest CAGR of 7.1% during the forecast period. The rapidly developing raw material industry in China and India, the growing number of local manufacturers for lateral flow assay components, increasing investments in the region by key market players, the availability of low-cost labor for manufacturing, and the presence of a favorable regulatory environment are the key factors driving market growth in the APAC. The current COVID-19 scenario and its high impact in the Asia Pacific region (especially India) have also resulted in a high growth rate in the lateral flow assay components market in this region.
Which is the leading product type in the lateral flow assay components market?
The lateral flow assay components market is segmented into membranes, pads, and others. In 2021, membranes accounted for the largest share of 58.8% of the global lateral flow assay components market. This segment is projected to reach USD 245.6 million by 2027 from 198.8 million in 2022, at a CAGR of 4.3% during the forecast period. The large share of this segment can be attributed to the increasing applications of lateral flow assay kits & reagents for POC testing, the growing burden of chronic diseases, the increasing use of lateral flow assay kits in home care settings, and their convenience and ease of use.
Which is the leading end user of the lateral flow assay components market?
Based on end users, the lateral flow assay components market is segmented into medical device manufacturing companies and medical device contract manufacturing companies. Medical device manufacturing companies accounted for the largest market share of 69.3% of the lateral flow assay components market in 2021. The COVID-19 pandemic has also increased the demand for point-of-care testing in professional healthcare settings, which increases the demand for lateral flow assay components among medical device manufacturing companies .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 33)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
1.5 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 36)
2.1 RESEARCH APPROACH
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Breakdown of primaries
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021)
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021)
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 KEY INDUSTRY INSIGHTS
2.5 LIMITATIONS
2.5.1 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
2.7 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 48)
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION)
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET
4 PREMIUM INSIGHTS (Page No. - 53)
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES
5 MARKET OVERVIEW (Page No. - 57)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Growing demand for lateral flow assay kits due to the COVID-19 pandemic
5.2.1.2 Growing usage of home-based lateral flow assay devices
5.2.1.3 Growing demand for point-of-care testing
5.2.1.4 Increasing public-private investments to develop lateral flow assays
5.2.2 RESTRAINTS
5.2.2.1 Availability of alternative diagnostic technologies
5.2.3 OPPORTUNITIES
5.2.3.1 Evolving applications of lateral flow assays
5.2.4 CHALLENGES
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
5.5 AVERAGE SELLING PRICE TREND
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS, BY REGION, 2021 (USD)
5.6 ECOSYSTEM MARKET MAP
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021)
5.7 PATENT ANALYSIS
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021
5.8 VALUE CHAIN ANALYSIS
5.9 REGULATORY LANDSCAPE
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION
5.9.1 NORTH AMERICA
5.9.2 EUROPE
5.9.3 ASIA PACIFIC
5.9.3.1 India
5.9.3.2 China
5.9.3.3 Japan
5.10 TECHNOLOGY ANALYSIS
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS
5.12.2 BUYING CRITERIA
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS
5.13 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.13.1 THREAT FROM NEW ENTRANTS
5.13.2 THREAT FROM SUBSTITUTES
5.13.3 BARGAINING POWER OF BUYERS
5.13.4 BARGAINING POWER OF SUPPLIERS
5.13.5 INTENSITY OF COMPETITIVE RIVALRY
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE (Page No. - 74)
6.1 INTRODUCTION
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
6.2 MEMBRANES
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION)
6.2.1 NITROCELLULOSE MEMBRANES
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS)
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS)
6.2.2 OTHER MEMBRANES
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION)
6.3 PADS
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.1 SAMPLE PADS
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.2 CONJUGATE PADS
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS, BY COUNTRY, 2020–2027 (USD MILLION)
6.3.3 ABSORBENT PADS
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS, BY COUNTRY, 2020–2027 (USD MILLION)
6.4 OTHER COMPONENTS
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION (Page No. - 86)
7.1 INTRODUCTION
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 CLINICAL TESTING
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.1 INFECTIOUS DISEASE TESTING
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.2 PREGNANCY & FERTILITY TESTING
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.3 CARDIAC MARKER TESTING
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING
7.2.4.1 Growing prevalence of obesity and CVD— a key factor driving market growth
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.5 DRUGS-OF-ABUSE TESTING
7.2.5.1 Technological advancements and a growing focus on workplace drug testing are driving market growth
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
7.2.6 OTHER CLINICAL TESTING APPLICATIONS
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.3 VETERINARY DIAGNOSTICS
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
7.5 DRUG DEVELOPMENT & QUALITY TESTING
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE (Page No. - 99)
8.1 INTRODUCTION
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
8.2 SANDWICH ASSAYS
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION)
8.3 COMPETITIVE ASSAYS
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION)
8.4 MULTIPLEX DETECTION ASSAYS
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION)
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER (Page No. - 104)
9.1 INTRODUCTION
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION (Page No. - 108)
10.1 INTRODUCTION
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
10.2 NORTH AMERICA
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.1 US
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US
TABLE 51 US: MACROECONOMIC INDICATORS
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US
TABLE 59 CANADA: MACROECONOMIC INDICATORS
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3 EUROPE
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany
TABLE 75 GERMANY: MACROECONOMIC INDICATORS
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France
TABLE 83 FRANCE: MACROECONOMIC INDICATORS
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.3 UK
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK
TABLE 91 UK: MACROECONOMIC INDICATORS
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country
TABLE 99 ITALY: MACROECONOMIC INDICATORS
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth
TABLE 107 SPAIN: MACROECONOMIC INDICATORS
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.1 CHINA
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country
TABLE 130 CHINA: MACROECONOMIC INDICATORS
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan
TABLE 138 JAPAN: MACROECONOMIC INDICATORS
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market
TABLE 146 INDIA: MACROECONOMIC INDICATORS
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.4.5 REST OF ASIA PACIFIC
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.5 LATIN AMERICA
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION)
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION)
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION)
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION)
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION)
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 178)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021)
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION
11.5 R&D ASSESSMENT OF KEY PLAYERS
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021)
11.7 COMPANY EVALUATION QUADRANT
11.7.1 STARS
11.7.2 PERVASIVE PLAYERS
11.7.3 EMERGING LEADERS
11.7.4 PARTICIPANTS
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021
11.8 COMPETITIVE BENCHMARKING
11.8.1 OVERALL COMPANY FOOTPRINT
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES)
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES)
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES)
11.9 COMPETITIVE SCENARIO
11.9.1 DEALS
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022
11.9.2 OTHER DEVELOPMENTS
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022
12 COMPANY PROFILES (Page No. - 190)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE)
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
12.1.2 SARTORIUS STEDIM BIOTECH
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW
12.1.3 MERCK KGAA
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 32 MERCK KGAA: COMPANY SNAPSHOT (2020)
12.1.4 AHLSTROM-MUNKSJÖ
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW
FIGURE 33 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020)
12.1.5 ADVANCED MICRODEVICES PVT. LTD.
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW
12.1.6 DCN DIAGNOSTICS
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW
12.2 OTHER PLAYERS
12.2.1 FORTIS LIFE SCIENCES
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.: BUSINESS OVERVIEW
12.2.3 AXIVA SICHEM BIOTECH
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW
12.2.4 NUPORE FILTRATION SYSTEM
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW
12.2.5 BALLYA BIO
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW
12.2.6 RUNBIO BIOTECH CO. LTD.
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW
12.2.7 NEENAH GESSNER
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW
12.2.8 MAXIM BIOMEDICAL
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW
12.2.9 CYTODIAGNOSTICS
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW
12.2.10 SENOVA GMBH
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 224)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
This study involved four major approaches in estimating the current lateral flow assay components market size. Extensive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the value market. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.
Secondary Research
This research study involved the extensive use of secondary sources; directories; databases such as Hoovers, Bloomberg Business, Factiva, and Avention; white papers; and annual reports, company house documents, and SEC filings of companies. Secondary research was used to identify and collect information useful for this extensive, technical, market-oriented, and commercial study of the global lateral flow assay components market. It was also used to obtain important information about top players, market classification, and segmentation according to industry trends to the bottom-most level, regional markets, and key developments related to market and technological perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the lateral flow assays market and lateral flow assay components market. Primary sources from the demand side include medical device manufacturing companies and medical device contract manufacturing companies.
A breakdown of the primary respondents for lateral flow assay components market (supply side) market is provided below:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The total size of the lateral flow assay components market was arrived at after data triangulation from different approaches as mentioned below. After completing each approach, the weighted average of the various approaches was taken based on the level of assumptions used in each approach.
Bottom-up Approach: Revenues of individual companies were gathered from public sources and databases. Shares of the lateral flow assay components businesses of leading players were gathered from secondary sources to the extent available. In certain cases, the share of the business unit was ascertained after a detailed analysis of various parameters, including product portfolio, market positioning, selling price, and geographic reach and strength. Individual shares or revenue estimates were validated through expert interviews.
Country level Analysis: The size of the lateral flow assay components market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of membrane, pads in the overall lateral flow assay components market was obtained from secondary data and validated by primary participants to arrive at the total lateral flow assay components market. Primary participants further validated the numbers.
Primary Interviews: As a part of the primary research process, individual respondent insights on the market size and growth were taken during the interview (regional and global, as applicable). All the responses were collated, and a weighted average was taken to derive a probabilistic estimate of the market size and growth rate.
Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall lateral flow assays market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Data Triangulation
After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed wherever applicable to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
Approach to derive the market size and estimate market growth
The market rankings for leading players were ascertained after a detailed assessment of their revenues from the lateral flow assay components business using secondary data available through paid and unpaid sources. Owing to data limitations, in certain cases, the revenue share was arrived at after a detailed assessment of the product portfolios of major companies and their respective sales performance. At each point, this data was validated through primary interviews with industry experts.
Objectives of the Study
- To define, describe, analyze, and forecast the lateral flow assay components market by type, application, technique, end user, and region
- To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall lateral flow assay components market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the lateral flow assay components market in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To strategically profile key players in the global lateral flow assay components market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as product launches, expansions, acquisitions, partnerships, agreements, and other developments of leading players in the global lateral flow assay components market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Product Analysis
- Further segmentation of individual product segments by application and end user
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific lateral flow assay components market into South Korea, New Zealand, and others
- Further breakdown of the Rest of Europe lateral flow assay components market into Belgium, Russia, the Netherlands, Switzerland, and others
Company Information
- Detailed analysis and profiling of additional market players (Up to 5)
Generating Response ...
Growth opportunities and latent adjacency in Lateral Flow Assay Components Market